** Medical device developer Bellerophon Therapeutics' shares
BLPH.O rise 72.9% to $5.93 premarket - biggest percentage
gainer across U.S. exchanges
** Tuesday's gains set to wipe out YTD losses
** Co says its device INOpulse was able to reduce resistance
in arteries that supply blood to lungs by 21% for patients with
pulmonary hypertension, high blood pressure within the lungs
urn:newsml:reuters.com:*:nGNXD4WN2
** Co's device supplies nitric oxide to patients based on
their breathing patterns
** More than 373k shares traded, 5.7 times their 25-DMA
(Reporting by Manas Mishra in Bengaluru)
((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709))